Add to Cart View Cart/Checkout More Products

Volume 6, 2002 CD

Six back issues of The International Journal of Pharmaceutical Compounding from 2002 on one convenient CD.
Only $95 per CD.
(Multiple Theme or Library CD orders priced at: 2 to 5 = $85; 6 to 9 = $75; 10 or more = $65 each.)

  • Permanant storage and easy retrieval of IJPC articles, formulations, SOP's and more.
  • Print IJPC articles in color for your marketing needs.

The back issues are stored as a high-resolution, full-color Adobe Portable Document Format (.pdf) file, complete with an electronic Table of Contents.

They may be searched by keyword and printed by the page. Software to read the PDF file is freely available from the Adobe Reader page.

Issues
Volume/IssueDateTitle
Vol. 6 No. 1 January/February 2002 Compounding for Pain Management and Dental Medicine
Vol. 6 No. 2 March/April 2002 Dermatologic Compounding
Vol. 6 No. 3 May/June 2002 Health, Wellness, Geriatrics
Vol. 6 No. 4 July/August 2002 Compounding for BHRT and Legal and Regulatory Issues
Vol. 6 No. 5 September/October 2002 Veterinary Compounding
Vol. 6 No. 6 November/December 2002 Sterile Preparations and Pediatric Compounding

Articles
Volume/IssuePageTitle
Vol. 6 No. 1 4 Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance
Vol. 6 No. 1 8 Compounding with Controlled Substances
Vol. 6 No. 1 11 The Problem of Drug Diversion
Vol. 6 No. 1 13 Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective
Vol. 6 No. 1 16 Compounding for Diseases of the Oral Cavity: A discussion with Stu Sommerville, RPh
Vol. 6 No. 1 17 Benzocaine 2% Sorbitol Antigag Candy
Vol. 6 No. 1 17 Tetracycline 5%, Dexamethasone 0.2% Periodontal Gel
Vol. 6 No. 1 17 Fluoride 0.25-mg Sugar-Free Hard Candy
Vol. 6 No. 1 19 Excerpts from and Reviews of Current Published Literature: Pain Management and Disorders of the Oral Cavity
Vol. 6 No. 1 24 Creating a Productivity Measurement Tool for a Home Infusion Pharmacy
Vol. 6 No. 1 27 Team Building For Success
Vol. 6 No. 1 31 Technology Spotlight: Capsule-Filling Machines
Vol. 6 No. 1 32 Compounding in History: Dental Considerations
Vol. 6 No. 1 33 Toothpowder
Vol. 6 No. 1 33 Liquid Dentifrice
Vol. 6 No. 1 33 Toothache Wax
Vol. 6 No. 1 34 Basics of Compounding Biotechnologic Preparations
Vol. 6 No. 1 40 Analgesic NSAID Suppositories
Vol. 6 No. 1 41 Capsaicin 0.075% Topical Spray
Vol. 6 No. 1 42 Clonidine HCl 0.2%, Gabapentin 6%, and Ketamine HCl 10% in a Pluronic Lecithin Organogel (PLO)
Vol. 6 No. 1 43 Diltiazem HCl 2% Topical Gel
Vol. 6 No. 1 44 Fentanyl 10-mcg/mL, Bupivacaine 5-mg/mL, and Baclofen 25-mcg/mL Injection
Vol. 6 No. 1 45 Fentanyl 100-mcg/0.1-mL in a Pluronic Lecithin Organogel (PLO)
Vol. 6 No. 1 46 Ketoprofen 12.5-mg, Phenyltoloxamine Citrate 30-mg, and Caffeine 30-mg Capsules
Vol. 6 No. 1 47 Morphine Sulfate 0.01%-Infused Silver Sulfadiazine (MISS) Cream
Vol. 6 No. 1 48 Morphine Sulfate 5-mg/0.1-mL Nasal Spray
Vol. 6 No. 1 49 Oxycodone 25-mg Slow-Release Capsules
Vol. 6 No. 1 50 Bioidentical Hormone Replacement Therapy, Part 2, A Review of
Vol. 6 No. 1 55 New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems
Vol. 6 No. 1 58 Poloxamers, Featured Excipient:
Vol. 6 No. 1 60 Safety for Employees in the Compounding Work Area
Vol. 6 No. 1 62 Physical and Chemical Stability of Morphine Sulfate 5-mg/mL and 50-mg/mL Packaged in Plastic Syringes
Vol. 6 No. 1 66 Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Clonidine Hydrochloride Packaged in Plastic Syringes
Vol. 6 No. 1 70 Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Bupivacaine Hydrochloride Packaged in Plastic Syringes
Vol. 6 No. 1 74 Physical and Chemical Stability of Hydromorphone Hydrochloride 1.5- and 80-mg/mL Packaged in Plastic Syringes
Vol. 6 No. 1 77 Calculations
Vol. 6 No. 1 80 PostScription: Regulatory Uncertainty Requires Professional Responsibility
Vol. 6 No. 2 85 Compounding for Skin Care: An Interview with John Hollis, RPh
Vol. 6 No. 2 88 Mary Kay Inc: Compounding in a Cosmetics Megacorporation
Vol. 6 No. 2 90 Hair Styling Gel Formula-Example Formulation
Vol. 6 No. 2 91 Skin Moisturizer Formula
Vol. 6 No. 2 91 Cream Formulation (Oil-in-Water Emulsion)
Vol. 6 No. 2 92 Options in Wound Care
Vol. 6 No. 2 96 Dermatologic and Cosmetic Lines from Compounding Pharmacies in Brazil
Vol. 6 No. 2 98 Excerpts from and Reviews of Current Published Literature: Treating Dermatologic Conditions
Vol. 6 No. 2 101 Book Review: The Wrinkle Cure
Vol. 6 No. 2 102 Basics of Compounding: Cosmetics for Special Populations and Using Cosmetics as Vehicles
Vol. 6 No. 2 103 Lotion
Vol. 6 No. 2 103 Dusting Powder
Vol. 6 No. 2 103 Hand Cream
Vol. 6 No. 2 104 Stick Formulation
Vol. 6 No. 2 104 Hard-Stick Formulation
Vol. 6 No. 2 104 Soft-Stick Formulation (Clear Stick Base)
Vol. 6 No. 2 104 Blemish-Hiding Stick
Vol. 6 No. 2 104 Clear Shampoo
Vol. 6 No. 2 104 Cream Shampoo
Vol. 6 No. 2 105 Liquid Deoderant and/or Antiperspirant
Vol. 6 No. 2 105 Shaving Cream (Brushless)
Vol. 6 No. 2 105 Shaving Cream (Brushless)
Vol. 6 No. 2 105 Astringent Mouthwash
Vol. 6 No. 2 105 Deodorant Stick
Vol. 6 No. 2 108 Developing a Successful Compounding Business in a Small Town
Vol. 6 No. 2 111 A Guide to Effective Media Relations
Vol. 6 No. 2 114 Technology Spotlight: Waring Blenders
Vol. 6 No. 2 116 Wish You Were Here: The History of Pharmacy Museum at the Arizona College of Pharmacy, Tucson, Arizona
Vol. 6 No. 2 118 Tablet Cutting
Vol. 6 No. 2 120 A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets
Vol. 6 No. 2 123 Medications Discontinued in the United States
Vol. 6 No. 2 126 Antipruritic Gel
Vol. 6 No. 2 127 Cold Sore Ointment
Vol. 6 No. 2 128 Glycolic Acid 15% Gel
Vol. 6 No. 2 129 Halobetasol and Calcipotriene Cream
Vol. 6 No. 2 130 Medicated Aftershave Lotion
Vol. 6 No. 2 131 Metronidazole 1% Topical Spray
Vol. 6 No. 2 132 Mycophenolate Mofetil 2% Topical Cream
Vol. 6 No. 2 133 Tranilast 0.8% for Iontophoresis
Vol. 6 No. 2 134 Tranilast Topical 2% Penetrating Mixture
Vol. 6 No. 2 135 Wart Remover Mixture
Vol. 6 No. 2 136 Veterinary Compounding for Ferrets
Vol. 6 No. 2 140 Sterilization of Talc for Use in Pleurodesis
Vol. 6 No. 2 142 Bioidentical Hormone Replacement Therapy, Part 3, A Review of
Vol. 6 No. 2 147 Polysorbates, Featured Excipient:
Vol. 6 No. 2 149 Standard Operating Procedure: Evaluating and Selecting an Analytical Testing Laboratory
Vol. 6 No. 2 151 Calculations
Vol. 6 No. 2 152 Stability of Gentamicin Sulfate and Tobramycin Sulfate in AutoDose Infusion System Bags
Vol. 6 No. 2 155 Stability of 4-Aminopyridine and 3,4-Diaminopyridine Oral Capsules
Vol. 6 No. 2 160 PostScription-Ensuring Compounding Excellence: Quality Control or Quality Assurance?
Vol. 6 No. 3 164 Healthful Living: Good Practices for Good Health
Vol. 6 No. 3 168 Compounding for Geriatrics Patients
Vol. 6 No. 3 171 Estrogen Replacement Therapy in the Treatment of Alzheimer's Disease
Vol. 6 No. 3 178 Lollipops: The Evolution of a Dosage Form
Vol. 6 No. 3 180 Book Reviews: Wellness, Nutrition and Geriatrics
Vol. 6 No. 3 184 Compounding in History: The Road to Wellville
Vol. 6 No. 3 185 Mild Laxative
Vol. 6 No. 3 185 Liver Pills for All Obstructions of the Liver, Gall Ducts, and Bowel
Vol. 6 No. 3 186 How To Perform a Study in Your Pharmacy with Little or No Effort
Vol. 6 No. 3 188 Technology Spotlight: Electric Mixing Machines
Vol. 6 No. 3 189 Treatment of Pain with a Topically Applied Combination of Indomethacin and Piroxicam
Vol. 6 No. 3 193 Medications Discontinued in the United States
Vol. 6 No. 3 194 Basics of Compounding: Iontophoresis, Part 1
Vol. 6 No. 3 199 Anhydrous Emollient Dry Skin Lotion
Vol. 6 No. 3 200 Antiseptic Protective Ointment
Vol. 6 No. 3 201 Camphor, Menthol, and Eucalyptol Rubefacient Ointment
Vol. 6 No. 3 202 Carbidopa 2-mg/mL and Levodopa 250-mg/mL Oral Suspension
Vol. 6 No. 3 203 Ergoloid Mesylates 15-mg/mL and Selegiline HCl 6.25-mg/mL in PLO
Vol. 6 No. 3 204 Misoprostol 0.0024%, Metronidazole 2%, and Pentoxifyline 5% Decubitus Ulcer Cream
Vol. 6 No. 3 205 Nicotine 2-mg Lollipops
Vol. 6 No. 3 206 Nicotine Medication Stick
Vol. 6 No. 3 207 Podophyllum, Lactic Acid, and Salicylic Acid Wart Mixture
Vol. 6 No. 3 208 Vitamin B12 1-mg/mL Nasal Spray
Vol. 6 No. 3 210 The Treatment of Canine Atopic Disease
Vol. 6 No. 3 216 pH and Osmolarity, A Review of
Vol. 6 No. 3 221 Sorbitan Esters, Featured Excipient:
Vol. 6 No. 3 224 Developing Standard Operating Procedures
Vol. 6 No. 3 226 Stability of Ampicillin Sodium, Nafcillin Sodium, and Oxacillin Sodium in AutoDose Infusion System Bags
Vol. 6 No. 3 230 Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs
Vol. 6 No. 3 234 Stability of Cefotaxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Vol. 6 No. 3 237 Calculations
Vol. 6 No. 3 240 PostScription: Building Relationships with Special Patient Populations
Vol. 6 No. 4 245 A Review of Current Research on the Effects of Progesterone
Vol. 6 No. 4 250 The Hormonal Link to Breast Cancer: The Estrogen Matrix
Vol. 6 No. 4 255 Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women
Vol. 6 No. 4 259 Establishing an Andropause Practice
Vol. 6 No. 4 263 Compounding and the Courts
Vol. 6 No. 4 267 Facilities and Procedures for Compounding Hazardous Drugs
Vol. 6 No. 4 271 Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer
Vol. 6 No. 4 274 Legal Issues: Technicians in the Compounding Pharmacy Practice
Vol. 6 No. 4 278 Excerpts from and Reviews of Current Published Literature: Pharmacy Administration and Other Topics of Interest
Vol. 6 No. 4 281 Magnetic Iron “Whiskers” in Cereals
Vol. 6 No. 4 284 Wish You Were Here: Chicago, Illinois
Vol. 6 No. 4 286 Medications Discontinued in the United States
Vol. 6 No. 4 288 Basics of Compounding for Iontophoresis, Part II
Vol. 6 No. 4 290 Lidocaine HCl 4% Solution for Iontophoresis
Vol. 6 No. 4 290 Dexamethasone 4-mg/mL Solution for Iontophoresis
Vol. 6 No. 4 290 Acetic Acid 2% Solution for Iontophoresis
Vol. 6 No. 4 291 Ketorolac 6-mg/mL Solution for Iontophoresis
Vol. 6 No. 4 293 Dehydroepiandrosterone 25-mg/mL in Pluronic Lecithin Organogel
Vol. 6 No. 4 294 Dehydroepiandrosterone 25-mg/0.25-mL Sublingual Drops
Vol. 6 No. 4 295 Estradiol 0.5-mg Sublingual Troches
Vol. 6 No. 4 296 Estradiol 1-mg/0.1-mL Pluronic Lecithin Organogel
Vol. 6 No. 4 297 Estradiol 1-mg/0.1-g Topical Cream
Vol. 6 No. 4 298 Estriol 2-mg/mL, Estrone 0.25-mg/mL, and Estradiol 0.25-mg/mL Topical Solution
Vol. 6 No. 4 299 Estriol 2-mg/mL Topical Gel
Vol. 6 No. 4 300 Estriol 2-mg and Estradiol 0.5-mg/0.1-mL Sublingual Drops
Vol. 6 No. 4 301 Testosterone 25-mg in Oil Capsules
Vol. 6 No. 4 302 Testosterone 50-mg/mL Topical Gel
Vol. 6 No. 4 303 Topical Oil-in-Water Cream Bases, Featured Excipient:
Vol. 6 No. 4 305 Calculations
Vol. 6 No. 4 306 Standard Operaing Procedure for the Quality Assessment of Nasal Solutions
Vol. 6 No. 4 308 Stability of Tubocurarine Chloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes
Vol. 6 No. 4 311 Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs
Vol. 6 No. 4 316 Stability of Ketamine Hydrochloride Injection After Reconstitution in Water for Injection and Storage in 1-mL Tuberculin Polypropylene Syringes for Pediatric Use
Vol. 6 No. 4 320 PostScription: Certification: Now Is the Time
Vol. 6 No. 5 324 Navigating New Territories in Compounding for Veterinary Medicine
Vol. 6 No. 5 328 Total Parenteral Nutrition for Animals
Vol. 6 No. 5 332 Veterinary Compounding for Hyperadrenocorticism (Cushing's Disease) in Dogs
Vol. 6 No. 5 337 Rites of Passage
Vol. 6 No. 5 338 Drug Therapy for Acute and Chronic Pain in the Cat
Vol. 6 No. 5 344 Transdermal Methimazole in the Treatment of 16 Cats with Hyperthyroidism
Vol. 6 No. 5 346 Excerpts from and Reviews of Current Published Literature: Veterinary Topics
Vol. 6 No. 5 349 Veterinary Book Reviews
Vol. 6 No. 5 350 Compounding in History: Equine Health
Vol. 6 No. 5 351 Spavin Treatment
Vol. 6 No. 5 351 Cough Ball (Veterinary)
Vol. 6 No. 5 351 Horse Liniment
Vol. 6 No. 5 354 Quality in Pharmacy: The New Zealand Experience
Vol. 6 No. 5 359 Third-Party Contracting for Compounding Pharmacies
Vol. 6 No. 5 362 Basics of Compounding: Phonophoresis
Vol. 6 No. 5 363 Ultrasound Gels-Carbopol Type
Vol. 6 No. 5 363 Ultrasound Gels-Hydoxyethyl Cellulose Type
Vol. 6 No. 5 364 Betamethasone Dipropionate 0.05% Gel for Phonophoresis
Vol. 6 No. 5 364 Piroxicam 0.5% Gel for Phonophoresis
Vol. 6 No. 5 364 Dexamethasone Sodium 0.4% Gel for Phonophoresis
Vol. 6 No. 5 364 Fluocinonide 0.1% Gel for Phonophoresis
Vol. 6 No. 5 364 Ketoprofen 2% Gel for Phonophoresis
Vol. 6 No. 5 364 Naproxen 5% Gel for Phonophoresis
Vol. 6 No. 5 364 Sodium Salicylate 10% Gel for Phonophoresis
Vol. 6 No. 5 364 Hydrocortisone 10% Gel for Phonophoresis
Vol. 6 No. 5 365 Dexamethasone 1.5% and Lidocaine HCl 4% Ultrasound Gel
Vol. 6 No. 5 365 Zinc Oxide 20% Gel
Vol. 6 No. 5 365 Iodine and Methylsalicylate Ultrasound Ointment
Vol. 6 No. 5 367 Erythromycin 400-mg/mL and Rifampin 50-mg/mL Oral Liquid
Vol. 6 No. 5 368 Ketoprofen 10% in Pluronic Lecithin Organogel
Vol. 6 No. 5 369 Oral Liquid Vehicle for Equine Use
Vol. 6 No. 5 370 Phenytoin Topical Powder
Vol. 6 No. 5 371 Tetracycline and Hydrocortisone Otic Suspension
Vol. 6 No. 5 372 Veterinary Carminative
Vol. 6 No. 5 373 Oral Liquid for Diarrhea
Vol. 6 No. 5 374 Veterinary Penicillamine 20-mg/mL Oral Liquid, Avian
Vol. 6 No. 5 375 Veterinary Thrush Formula, Equine
Vol. 6 No. 5 376 Veterinary Topical Anesthetic and Astringent Gel
Vol. 6 No. 5 377 Satisfaction of Patients Using Bioidentical Hormones for Hormone Replacement Therapy
Vol. 6 No. 5 378 Custom-Compounded Micronized Hormones in a Slow-Release Capsule Matrix
Vol. 6 No. 5 380 Featured Excipient: Specially Denatured Alcohols
Vol. 6 No. 5 384 Collecting Laboratory and Other Clinical Efficacy Data on Veterinary Patients
Vol. 6 No. 5 387 Calculations
Vol. 6 No. 5 388 Stability of Lidocaine Hydrochloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes
Vol. 6 No. 5 391 Effect of Freezing, Long-Term Storage, and Microwave Thawing on the Stability of Cefepime in 5% Dextrose Infusion Polyvinyl Chloride Bags
Vol. 6 No. 5 395 Chemical Stability of Dexamethasone Sodium Phosphate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes
Vol. 6 No. 5 400 PostScription: Exec. VP & CEO NCPA
Vol. 6 No. 6 404 The Cost of Quality in Pharmacy
Vol. 6 No. 6 408 Comparison of Endotoxin Testing Methods for Pharmaceutical Products
Vol. 6 No. 6 410 Phenytoin Injections: From Compounding to Cerebyx
Vol. 6 No. 6 414 Book Review: Sterile Compounding
Vol. 6 No. 6 415 Sterile Compounding of Respiratory Inhalation Solutions
Vol. 6 No. 6 419 Pediatric Dermatitis
Vol. 6 No. 6 423 Excerpts from and Reviews of Current Published Literature: Pediatric Medications
Vol. 6 No. 6 424 Book Reviews: Compounding for Pediatric Patients
Vol. 6 No. 6 428 Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 1
Vol. 6 No. 6 434 Regulatory and Operational Issues of Founding a Compounding Pharmacy
Vol. 6 No. 6 439 Technology Spotlight: Liquid-Filling Machines
Vol. 6 No. 6 441 Medications Discontinued in the United States
Vol. 6 No. 6 443 Basics of Compounding: Clinical Studies
Vol. 6 No. 6 448 Benzalkonium Chloride 1:750 Solution for Cold Disinfection
Vol. 6 No. 6 449 Caffeine and Sodium Benzoate 250-mg/mL Injection
Vol. 6 No. 6 450 Dexamethasone Sodium Phosphate 4-mg/mL Injection
Vol. 6 No. 6 451 Dimenhydrinate 50-mg/mL Injection
Vol. 6 No. 6 452 Erythromycin and Dexamethasone Ophthalmic Solution
Vol. 6 No. 6 453 Furosemide 10-mg/mL Injection
Vol. 6 No. 6 454 Hydromorphone HCl 0.1-mg/mL Injection for Patient-Controlled Analgesia
Vol. 6 No. 6 455 Methadone HCl 1-mg/mL, 2-mg/mL, and 5-mg/mL Injection
Vol. 6 No. 6 456 Morphine Sulfate 2-mg/mL and Droperidol 0.08-mg/mL Injection for Patient-Controlled Analgesia
Vol. 6 No. 6 457 Phenobarbital Sodium 130-mg/mL Injection
Vol. 6 No. 6 458 Andropause: A Review of Treatment Options
Vol. 6 No. 6 462 Featured Excipient: Disinfecting Agents
Vol. 6 No. 6 465 Calculations
Vol. 6 No. 6 466 Cleaning and Disinfection
Vol. 6 No. 6 468 Chemical Stability of Furosemide in Minibags and Polypropylene Syringes
Vol. 6 No. 6 471 pH Stability of Injectable Fentanyl, Bupivacaine, or Clonidine Solution or a Ternary Mixture in 0.9% Sodium Chloride in Two Types of Polypropylene Syringes
Vol. 6 No. 6 475 Stability of Neostigmine Methylsulfate Injection at Ambient Temperature and 4°C in Polypropylene Syringes
Vol. 6 No. 6 480 PostScription: The Times They Are A-Changin